Markers of early cardiotoxicity in patients with breast cancer undergoing chemotherapy depending on blood pressure level

Markers of early cardiotoxicity in patients with breast cancer undergoing chemotherapy depending on blood pressure level

Objective. To study the possibility of the 2D Speckle Tracking Imaging in early detection of cardiotoxicity in patients with triple negative breast cancer and arterial hypertension (AH) during anthracycline-containing chemotherapy. Materials and methods. 70 women (mean age 48.6±13.3 years) with trip...

Full description

Bibliographic Details
Main Authors:	A A Avalyan, M Yu Kirillova, V N Shitov, Ye V Oshchepkova, M A Saidova, M B Stenina, I Ye Chazova
Format:	Article
Language:	Russian
Published:	IP Morozov P.V. 2017-12-01
Series:	Системные гипертензии
Subjects:	cardio-oncology arterial hypertension cardiotoxicity global longitudinal strain of the left ventricle chemotherapy breast cancer
Online Access:	https://syst-hypertension.ru/2075-082X/article/viewFile/29581/pdf

Similar Items

Uncontrolled arterial hypertension in patients with breast cancer and the risk of developing cardiotoxicity with anthracycline-containing chemotherapy
by: Elena V Oshchepkova, et al.
Published: (2019-12-01)

Evaluation of subclinical cardiotoxicity in patients with breast cancer and arterial hypertension in two regimens of anthracycline-containing chemotherapy
by: A A Avalyan, et al.
Published: (2018-12-01)

Right ventricle involvement in patients with breast cancer treated with chemotherapy
by: Ludovico Rossetto, et al.
Published: (2024-04-01)

The Role of Speckle Strain Echocardiography in the Diagnosis of Early Subclinical Cardiac Injury in Cancer Patients—Is There More Than Just Left Ventricle Global Longitudinal Strain?
by: Michal Laufer-Perl, et al.
Published: (2021-01-01)

Comparative capabilities of the speckle-tracking echocardiography technologiesin two-dimensional and three-dimensional modes in the detection of subclinical cardiotoxicity in patients with breast cancer
by: M. A. Saidova, et al.
Published: (2020-12-01)

Prevalence of Right Ventricle Strain Changes following Anthracycline Therapy
by: Michal Laufer-Perl, et al.
Published: (2022-02-01)

Cardio-oncology: what you need to know now for clinical practice and echocardiography
by: Carolyn M Larsen, et al.
Published: (2017-04-01)

Cancer therapy-induced cardiotoxicity: Review and algorithmic approach toward evaluation
by: K Purkayastha, et al.
Published: (2017-01-01)

Atrial Strain Assessment for the Early Detection of Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer Women (The STRANO STUDY: Atrial Strain in Cardio-Oncology)
by: Daniela Di Lisi, et al.
Published: (2023-11-01)

Left ventricular diastolic function and cardiotoxic chemotherapy
by: Haider Rashid, et al.
Published: (2024-04-01)

Early Detection and Prediction of Anthracycline-Induced Right Ventricular Cardiotoxicity by 3-Dimensional Echocardiography
by: Rui Zhao, MBBS, et al.
Published: (2020-03-01)

Influence of trimetazidine on myocardium energy balance during chemotherapy with doxorubicin and cyclophosphamide
by: A. A. Avagimyan
Published: (2022-06-01)

Developing a comprehensive Cardio-Oncology Program at a Cancer Institute: the Moffitt Cancer Center experience
by: Michael G. Fradley, et al.
Published: (2017-07-01)

Relationship between Chemotherapy and Atrial Fibrillation: Clinical Case
by: A. A. Avagimyan, et al.
Published: (2021-11-01)

Speckle-tracking echocardiography in 3D mode in assessing the deformation of the myocardium and identifying subclinical cardiotoxicity during chemotherapy in breast cancer patients with arterial hypertension
by: Ani A. Avalyan, et al.
Published: (2020-10-01)

Development of a Cardio-Oncology Service in Lithuania: Prediction, Prevention, Monitoring and Treatment of Cancer Treatment-Induced Cardiotoxicity
by: Eglė Čiburienė, et al.
Published: (2022-04-01)

Cardiotoxicity and Chemotherapy—The Role of Precision Medicine
by: Thyla Viswanathan, et al.
Published: (2021-12-01)

The Potential Cardiotoxicity of Immune Checkpoint Inhibitors
by: Inbar Nardi Agmon, et al.
Published: (2022-02-01)

The broad spectrum of cardiotoxicities from immunotherapies
by: Martina Iengo, et al.
Published: (2023-09-01)

ECG Scoring for the Evaluation of Therapy-Naïve Cancer Patients to Predict Cardiotoxicity
by: Julia Pohl, et al.
Published: (2021-03-01)

Exercise Cardio-Oncology: Exercise as a Potential Therapeutic Modality in the Management of Anthracycline-Induced Cardiotoxicity
by: Dong-Woo Kang, et al.
Published: (2022-01-01)

POSSIBILITIES OF IVABRADINE, A SELECTIVE INHIBITOR OF ION F-CHANNELS OF SINUS NODE, IN PREVENTION OF ANTHRACYCLINE CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER
by: Yu. V. Vasyuk, et al.
Published: (2017-05-01)

Potential of primary drug prevention of cardiotoxicity in the context of anticancer therapy
by: Yu. A. Vasyuk, et al.
Published: (2023-01-01)

New Insights on the Toxicity on Heart and Vessels of Breast Cancer Therapies
by: Oreste Lanza, et al.
Published: (2022-05-01)

Cardiotoxicity and Cardiovascular Biomarkers in Patients With Breast Cancer: Data From the GeparOcto‐GBG 84 Trial
by: Alexandra Maria Rüger, et al.
Published: (2020-12-01)

Doxorubicin-induced cardiotoxicity is mediated by neutrophils through release of neutrophil elastase
by: Anchit Bhagat, et al.
Published: (2022-08-01)

Novel Therapeutics for Anthracycline Induced Cardiotoxicity
by: Jacqueline T. Vuong, et al.
Published: (2022-04-01)

Potential Role of Global Longitudinal Strain in Cardiac and Oncological Patients Undergoing Cardio-Oncology Rehabilitation (CORE)
by: Gianluigi Cuomo, et al.
Published: (2023-03-01)

Practical Approaches to Build and Sustain a Cardio-Oncology Clinic
by: Angeliki Chasouraki, et al.
Published: (2022-05-01)

Atrial fibrillation in a patient with lung cancer: a case report
by: E. Yu. Shupenina, et al.
Published: (2022-12-01)

Automated Global Longitudinal Strain Assessment in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia
by: Rafael Gonzalez-Manzanares, et al.
Published: (2022-03-01)

Rationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapy
by: Anthony F. Yu, et al.
Published: (2023-03-01)

Hypertensive Cardiotoxicity in Cancer Treatment—Systematic Analysis of Adjunct, Conventional Chemotherapy, and Novel Therapies—Epidemiology, Incidence, and Pathophysiology
by: Robin Chung, et al.
Published: (2020-10-01)

Ivabradine for the Prevention of Anthracycline-Induced Cardiotoxicity in Female Patients with Primarily Breast Cancer: A Prospective, Randomized, Open-Label Clinical Trial
by: Eglė Čiburienė, et al.
Published: (2023-12-01)

Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity
by: Manrose Singh, et al.
Published: (2022-01-01)

Management of Cardiac Toxicity Induced by Chemotherapy
by: Dario Trapani, et al.
Published: (2020-09-01)

CHEMOTHERAPY CARDIOTOXICITY SCREENING WITH CARDIAC TROPONINS
by: O. V. Krikunova, et al.
Published: (2015-12-01)

A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
by: Ana de la Fuente, et al.
Published: (2022-06-01)

Evolving field of cardio-oncology
by: Guo Li, et al.
Published: (2023-04-01)

Detection of right ventricular dysfunction by three – dimensional echocardiography and two - dimensional speckle tracking in breast cancer patients receiving anthracycline- based chemotherapy
by: Wafaa S. El-Sherbeny, et al.
Published: (2023-04-01)